Doctor profile · Federal record
Dr. Recaredo Berbano, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · New York, NY
- NPI 1942275748
- Accepts Medicare
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
222 E 31St St Apt 1R
New York, NY 100166333
(315) 201-0621 - Additional location
-
241 Claremont Ave
Tamaqua, PA 182524302
(570) 225-7211
fax (570) 501-7939 - Additional location
-
445 Wyoming Avenue
Kingston, PA 18704
(570) 718-0520
fax (570) 718-0522 - Mailing address
-
Po Box 783311
Philadelphia, PA 191783311
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- December 1, 2023
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Pennsylvania #MD 418103
- Medicaid (3)
- PA #001887950-0005 · PA #0018879500003 · NY #07675556
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1942275748. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
27
Distinct HCPCS
1
Medicare allowed
$5,563
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 27 | 12 | $206 |
In context: peer comparison
Among 92 peers in this city , average services per provider: 220. This provider delivers 0.1× the peer median.Open Payments
Industry payments received
All-time total
$2,161
Transactions
83
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 35 | $718.83 | |
| Novo Nordisk Inc | 13 | $376.10 | |
| Astellas Pharma US Inc | 6 | $219.52 | |
| Ascensia Diabetes Care Us Inc. | 3 | $175.86 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $166.75 | |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $117.95 | |
| Xeris Pharmaceuticals, Inc. | 4 | $79.09 | |
| Dexcom, Inc. | 2 | $64.10 | |
| ViiV Healthcare Company | 2 | $56.41 | |
| Intra-Sana Laboratories | 2 | $37.15 | |
| Hologic Sales and Service, LLC | 1 | $35.93 | |
| Antares Pharma, Inc. | 1 | $30.01 | |
| Tandem Diabetes Care, Inc. | 1 | $24.75 | |
| Insulet Corporation | 1 | $22.99 | |
| Medtronic, Inc. | 1 | $21.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
92
Patients
14
Total drug cost
$40,814
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 39 | 0 | $39,911 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 33 | 14 | $612 |
| Levothyroxine Sodium | Generic | 20 | 0 | $291 |
Frequently asked questions
What is Dr. Recaredo Berbano's medical specialty?
Dr. Recaredo Berbano practices Endocrinology, Diabetes & Metabolism Physician in New York, NY.
Where does Dr. Recaredo Berbano practice?
Dr. Recaredo Berbano practices at 222 E 31St St Apt 1R, New York, NY 100166333. Office phone: 3152010621.
What is Dr. Recaredo Berbano's NPI?
Dr. Recaredo Berbano's National Provider Identifier (NPI) is 1942275748, issued by NPPES.
Does Dr. Recaredo Berbano accept Medicare assignment?
Yes. Dr. Recaredo Berbano accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Recaredo Berbano commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.